Tourmaline Bio

Yahoo Finance • 2 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WOW, PRO, TRML, PGRE on Behalf of Shareholders

NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to sharehold... Full story

Yahoo Finance • 2 days ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: PROS Holdings, Inc. (NYSE – PROS), Paramount Group, Inc. (NYSE – PGRE), Tourmaline Bio, Inc. (Nasdaq - TRML), WideOpenWest, Inc. (NYSE - WOW)

BALA CYNWYD, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ac... Full story

Yahoo Finance • 7 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PGRE, WOW, TRML, BTBD on Behalf of Shareholders

NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to sharehold... Full story

Yahoo Finance • 7 days ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Paramount Group, Inc. (NYSE – PGRE), Tourmaline Bio, Inc. (Nasdaq - TRML), BT Brands, Inc. (Nasdaq - BTBD), WideOpenWest, Inc. (NYSE - WOW)

BALA CYNWYD, Pa., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ac... Full story

Yahoo Finance • 11 days ago

Top global stories this week: Anglo-Teck, Taiwan Semiconductor among notable names

[Businesspeople walking across painted world map, carrying moving boxes] Klaus Vedfelt/DigitalVision via Getty Images Most major stock indexes across the globe ended the week higher, tracking gains and record closes on the Wall Street,... Full story

Yahoo Finance • 13 days ago

Unusual volume stocks in Thursday's session

In today's session, these stocks are experiencing unusual volume. [unusualvolume] UNUSUAL VOLUME STOCKS TICKER CHANGE COMMENT DSY [https://www.chartmill.com/stock/quote/DSY/profile] 10.56% With 3.5M shares traded so far,... Full story

Yahoo Finance • 15 days ago

Stock market today: Dow, S&P 500, Nasdaq climb to records as sharp jobs revision sets stage for inflation data

US stocks hit fresh records on Tuesday as investors digested a revision to US jobs numbers that showed further labor market weakness and braced for key inflation data that could reset expectations for interest-rate cuts. The Dow Jones Ind... Full story

Yahoo Finance • 15 days ago

Let's take a look at the stocks that are in motion in today's session.

Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE COMMENT... Full story

Yahoo Finance • 15 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TRML, WOW, BTBD, WKHS on Behalf of Shareholders

NEW YORK, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to sharehold... Full story

Yahoo Finance • 15 days ago

This Small Biotech Stock Is Surging Today. Here's Why.

FABRICE COFFRINI / AFP via Getty Images Novartis is offering $1.4 billion to buy Tourmaline Bio, the developer of cardiovascular drug pacibekitug. KEY TAKEAWAYS Novartis said Tuesday it is buying Tourmaline Bio for $1.4 billion, in a dea... Full story

Yahoo Finance • 15 days ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Tourmaline Bio, Inc. (Nasdaq - TRML), BT Brands, Inc. (Nasdaq - BTBD), WideOpenWest, Inc. (NYSE - WOW), Workhorse Group Inc. (Nasdaq - WKHS)

BALA CYNWYD, Pa., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ac... Full story

Yahoo Finance • 16 days ago

Stock market today: Dow, S&P 500, Nasdaq nudge up as Wall Street braces for revision to jobs data

US stocks crept higher on Tuesday as investors waited for a revision to jobs numbers, seen as likely to show further labor-market weakness that could reset expectations for interest-rate cuts. The Dow Jones Industrial Average (^DJI) nudge... Full story

Yahoo Finance • 16 days ago

Novartis To Expand Heart Drug Portfolio With $1.4 Billion Tourmaline Bio Acquisition

Tourmaline Bio, Inc. (NASDAQ:TRML) shares surged Tuesday after Novartis AG (NYSE:NVS) announced a $1.4 billion acquisition of the U.S.-based biotech, strengthening the Swiss drugmaker’s pipeline of cardiovascular and kidney treatments. No... Full story

Yahoo Finance • 16 days ago

Tourmaline Bio Enters into Agreement to be Acquired by Novartis AG

– Novartis to acquire Tourmaline Bio for $48.00 per share in cash for a total equity value of approximately $1.4 billion – – Transaction reflects the potential of Tourmaline’s pacibekitug, a long-acting, fully-human, anti-IL-6 monoclonal... Full story

Yahoo Finance • 16 days ago

Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD)

Tourmaline Bio is a clinical-stage biopharmaceutical company developing pacibekitug, an anti-IL-6 mAb, as a treatment option for atherosclerotic cardiovascular disease Pacibekitug is a promising targeted therapy with the potential to reduc... Full story

Yahoo Finance • 24 days ago

Tourmaline Bio highlights positive phase 2 pacibekitug data

Tourmaline Bio (NASDAQ:TRML [https://seekingalpha.com/symbol/TRML]) on Sunday presented [https://seekingalpha.com/pr/20216458-tourmaline-bio-presents-data-from-the-ongoing-phase-2-tranquility-trial-at-the-2025-european] additional data fro... Full story

Yahoo Finance • 25 days ago

Tourmaline Bio Presents Data from the Ongoing Phase 2 TRANQUILITY Trial at the 2025 European Society of Cardiology Congress

– Poster presentation highlights the consistency of reductions in high-sensitivity C-reactive protein with pacibekitug across clinically-meaningful subgroups – – Pacibekitug demonstrated concordant, statistically significant reductions in... Full story

Yahoo Finance • last month

Talaris Therapeutics GAAP EPS of -$0.90

* Talaris Therapeutics press release [https://seekingalpha.com/pr/20199100-tourmaline-bio-reports-second-quarter-2025-financial-results-and-recent-business-highlights] (NASDAQ:TRML [https://seekingalpha.com/symbol/TRML]): Q2 GAAP EPS of... Full story

Yahoo Finance • last month

Form 8K Tourmaline Bio Inc For: 13 August

... Full story

Yahoo Finance • last month

Tourmaline Bio Reports Second Quarter 2025 Financial Results and Recent Business Highlights

– Reported positive topline results from the ongoing Phase 2 TRANQUILITY trial of pacibekitug in May 2025, demonstrating rapid, deep, and durable reductions in high-sensitivity C-reactive protein with quarterly dosing – — Additional data... Full story